Neuron-Derived MIF Engages VCAM1 to Fuel a Self-Amplifying CXCL8 Loop That Drives Perineural Invasion and Metastasis in Gastric Cancer
- Adv Sci (Weinh). 2026 Jun 22:e76195. doi: 10.1002/advs.76195.
- 1. Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
- 2. Department of Thyroid And Breast Surgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province, China.
- 3. Cancer Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.
- 4. Department of Gastrointestinal and Hernia Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, Jiangxi Province, China.
Background: Perineural invasion (PNI) is common in gastric Cancer and predicts poor prognosis, but the molecular mechanisms underlying tumour-nerve crosstalk remain unclear.
Methods: Transcriptomic data from TCGA and GEO were integrated to identify PNI regulators, with validation in surgical specimens. Mechanistic studies used tumor-neuron Transwell co-culture, siRNA/lentiviral perturbation, Western blot, immunofluorescence, ELISA, co-immunoprecipitation, and GST pull-down. Functional effects were assessed via CCK-8/Transwell assays, a sciatic nerve invasion xenograft model, and an orthotopic gastric Cancer model with neuron-specific MIF conditional knockout mice.
Results: High CXCL8/VCAM1 expression correlates with poor overall survival, distant metastasis, and is upregulated in PNI-positive tumours. Mechanistically, CXCL8 promotes neuronal MIF expression, while MIF directly binds VCAM1 and enhances tumour CXCL8 expression. VCAM1-mediated CXCL8 upregulation drives tumour proliferation and invasion. In vivo, blocking CXCL8/VCAM1 or neuron-specific MIF deletion reduces tumour growth and neural invasion.
Conclusions: A MIF-VCAM1-CXCL8 positive-feedback axis linking neural activity to gastric Cancer progression and PNI is identified, providing prognostic biomarkers and actionable therapeutic targets.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: CXCR